Duloxetine Treatment of Major Depression and Chronic Low Back Pain For Older Adults
Status:
Completed
Trial end date:
2010-04-01
Target enrollment:
Participant gender:
Summary
The following primary hypotheses will be tested:
1. During Step 1: Major Depressive Disorder (MDD) or Chronic Low Back Pain (CLBP) in < 40%
of the initial 60 subjects treated with duloxetine (DUL) + Clinical Management(CM)
during the first 8 weeks will respond (response is defined as a Montgomery Asberg
Depression Rating Scale (MADRS) score Phase:
Phase 4
Details
Lead Sponsor:
University of Pittsburgh
Collaborators:
Eli Lilly and Company National Institutes of Health (NIH)